drugset / Trial / NCT07704372
Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate the efficacy and safety of superoxide dismutase skin spray for the reducing the acute radiation dermatitis in patients with head and neck malignancies undergoing radiotherapy.
Timeline
- Start
- 2026-07-15
- Primary completion
- 2026-12-30
- Completion
- 2027-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORGOTEIN | Protein / enzyme biologic | — | Topical |